TP53 and prostate cancer: Our previous studies demonstrate that EGCG-mediated apoptosis stabilizes p53 by phosphorylation on critical serine residues in human prostate cancer LNCaP cells harboring wild type p53, suggesting that endogenous p53 is a critical determinant of EGCG-induced apoptosis [28].